Cystic Fibrosis Foundation - Click here for homepage
Stay Informed  |  Volunteer  |  Clinical Trials

In This Section

Quick Links

Find a Chapter

Get Assistance

Get Assistance - Cox Boys
We are here to help people with CF get the insurance coverage they need. Hear how the Foundation helped the Cox family.

Join us on Facebook!  Facebook 
Follow us on Twitter!   Twitter
Follow us on Instagram!  Instagram 
Add us to your circle in Google+!


Subscribe to our channel on YouTube!  YouTube  



Bookmark and Share   Print  
FDA Announces Recall of Selected Zicam Extreme Congestion Relief Nasal Gel

December 19, 2012

The U.S. Food and Drug Administration (FDA) has notified consumers of a voluntary recall of a selected lot of Zicam® Extreme Congestion Relief nasal gel by Matrixx Initiatives.

Matrixx initiated the recall after the company found a small amount of the bacteria Burkholderia cepacia (B. cepacia) in a single sample of the product taken from the affected lot. Tests on additional samples from the same lot have shown no evidence of B. cepacia.

The recall is for Zicam Extreme Congestion Relief, lot 2J23, expiration 09/15.

The product is a non-drip liquid nasal gel used as a nasal decongestant. It is packaged in a 0.5-oz. spray bottle and contained in an outer carton that has the NDC number 62750-005-10. The product was distributed to retailers nationwide throughout the United States.

Consumers who have the affected lot of Zicam Extreme Congestion Relief nasal gel should stop using the product. People with cystic fibrosis who have used the recalled product should speak with their CF physician or health care provider.

B. cepacia in a nasal spray could cause upper airway colonization by the bacteria and could lead to respiratory infections in individuals with a compromised immune system or those with chronic lung conditions, such as CF. B. cepacia is resistant to many antibiotics and may be difficult to eradicate in these individuals if an infection occurs.

To view a photo of the recalled product, visit the FDA website.

To get a full refund, call Matrixx at 1-877-942-2626, 8 a.m. – 8 p.m. (Central time), Monday – Friday, and 9 a.m. – 1 p.m., Saturday.

For more information on the recall, call Matrixx at 1-877-942-2626 at the times above or visit

For more information, read the FDA announcement.

The Cystic Fibrosis Foundation is an accredited charity of the Better Business Bureau.